News: Dexa Group

16 November 2022

Figures of Indonesia Indigenous Modern Medicine Receive Honorary Title of Adjunct Professorship from Atma Jaya Catholic University

Dr. Raymond Rubianto Tjandrawinata, a leading figure in Indonesia Indigenous Modern Medicine (OMAI), was awarded the honorary title of Adjunct Professor in Pharmaceutical Biotechnology by the Indonesian Catholic University (Unika) Atma Jaya Jakarta. Dr. Raymond Rubianto Tjandrawinata has demonstrated a scientific discovery and contribution to the advancement of pharmaceutical biotechnology,…
9 November 2022

Dexa Group Leader's Public Lecture at Sanata Dharma University: Building Independence as a Dexa Group Contribution

Mr. Ferry Soetikno, the leader of the Dexa Group, served as a speaker during the Sanata Dharma University Yogyakarta Public Lecture. During his guest lecture, Mr. Ferry covered two subjects for hundreds of University of Sanata Dharma students and graduates: the introduction of Dexa Medica and the independence of pharmaceuticals…
4 November 2022

Dexa Group Supports Domestic Pharmacy Industry Resilience and Independence

Dexa Group took part in the 58th National Health Day Exhibition's Opening Ceremony on Thursday, November 3, 2022, at the Indonesia Convention Exhibition (ICE) BSD, Tangerang. With the theme Indonesian Pharmacy Resilience and Independence, Dexa Group set up a booth at the event. The occasion was attended by the Minister…
24 October 2022

Dexa Group and BKKBN Collaboration to Pursue Stunting Reduction Target of 14% in 2024

Dexa Group partnered with the National Population and Family Planning Agency (BKKBN) RI to host an Exclusive Nursing and Education program for pregnant women and breastfeeding mothers in Brebes Regency during the First 1,000 Days of Life. This program was carried out as a joint commitment to accelerate the reduction…
21 October 2022

Grow Faster and Stronger, Dexa Medica has Won the Indonesia Living Legend Companies 2022 Award After 53 Years of Consistency

PT Dexa Medica has been growing and innovating in the health sector for the past 53 years. Dexa Medica has received the Indonesia Living Legend Companies 2022 award from SWA Magazine for its achievements over the last half-century. Indonesia Living Legend Companies is an award intended for companies established in…
20 October 2022

Reinforcing Pharmaceutical Products Export Commitment to Europe, Dexa Group Signs MoU with Dutch and Polish Companies

Dexa Group, a pharmaceutical company with a high international standard in Indonesia, has reaffirmed its commitment to exporting its goods to Europe. Dexa Group inked a collaboration agreement with Allgen Pharmaceutical & Generic B.V from the Netherlands and Bioton S.A from Poland through its subsidiary Ferron Par Pharmaceuticals. Allgen Pharmaceutical…
19 October 2022

President Jokowi Visits Dexa Group Booth at Trade Expo Indonesia 2022

The President of the Republic of Indonesia, Joko Widodo (Jokowi), visited the Dexa Group booth at the 2022 Trade Expo Indonesia (TEI) at ICE BSD City, Tangerang, Mr. Dexa Group Commissioner, Mrs. Gracianti Soetikno-Pandji, welcomed the President. The President was accompanied by the Coordinating Minister for the Economy of the…
28 September 2022

Dexa Group is Committed to Improving Health Services through Renovation Assistance for Inpatient Rooms at TNI AD Hospital, dr. AK Gani Palembang

Following the 53rd anniversary, Dexa Group and the Indonesian Army Health Center officially opened the renovated inpatient room at the Tk II Hospital, dr. AK Gani, Palembang. Dexa Group's devotion to providing public health services and support for the National Health Insurance (JKN) program can be seen in the refurbishment…
12 September 2022

Synergy of Dexa Group, National Population, and Family Planning Agency, and Indonesian Midwives Association to Pursue a 14% Reduction of Stunting in 2024

According to the Indonesian Toddler Nutrition Status Survey (SSGBI), the incidence of stunting in Indonesia remains at 24.4%, much behind the 14% objective set by the 2020-2024 National Medium-Term Development Plan (RPJMN). For that purpose, Dexa Group cooperated with the National Population and Family Planning Agency (BKKBN) to host a…
1 September 2022

More Than 17 Years Trusted by Indonesian Families, STIMUNO Wins Indonesian Mom's Favorite Brand Choice Awards 2022

For more than 17 years, STIMUNO, the first phytopharmaca immunomodulator in Indonesia, had been relied on by the Indonesian Family to support the health of their immune systems. For this accomplishment, STIMUNO earned the Top 5 Indonesian Mom's Favorite Brands for Multivitamin Category in the Household & Personal Care (non-food)…